{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:13:35Z","timestamp":1790709215600,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1124\/jpet.116.238261","type":"journal-article","created":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T03:10:43Z","timestamp":1483672243000},"page":"435-444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Niacin Promotes Cardiac Healing after Myocardial Infarction through Activation of the Myeloid Prostaglandin D2 Receptor Subtype 1"],"prefix":"10.1016","volume":"360","author":[{"given":"Deping","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanjuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guizhu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengkai","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Breyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.116.238261_bib1","doi-asserted-by":"crossref","first-page":"15277","DOI":"10.1074\/jbc.M506431200","article-title":"Structural and functional characterization of HQL-79, an orally selective inhibitor of human hematopoietic prostaglandin D synthase","volume":"281","author":"Aritake","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.116.238261_bib2","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1172\/JCI23626","article-title":"GPR109A (PUMA-G\/HM74A) mediates nicotinic acid-induced flushing","volume":"115","author":"Beny\u00f3","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.116.238261_bib3","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"Boden","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.116.238261_bib4","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0735-1097(86)80293-5","article-title":"Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin","volume":"8","author":"Canner","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/jpet.116.238261_bib5","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.0954-6820.1963.tb17457.x","article-title":"Studies on the effect of nicotinic acid on catecholamine stimulated lipolysis in adipose tissue in vitro","volume":"173","author":"Carlson","year":"1963","journal-title":"Acta Med Scand"},{"key":"10.1124\/jpet.116.238261_bib6","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.0954-6820.1962.tb07203.x","article-title":"The effect of nicotinic acid on the plasma free fatty acid; demonstration of a metabolic type of sympathicolysis","volume":"172","author":"Carlson","year":"1962","journal-title":"Acta Med Scand"},{"key":"10.1124\/jpet.116.238261_bib7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.0954-6820.1988.tb15891.x","article-title":"Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid","volume":"223","author":"Carlson","year":"1988","journal-title":"Acta Med Scand"},{"key":"10.1124\/jpet.116.238261_bib8","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1073\/pnas.0601574103","article-title":"Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans","volume":"103","author":"Cheng","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.116.238261_bib9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3109\/09537104.2011.565433","article-title":"The effects of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin","volume":"22","author":"Dallob","year":"2011","journal-title":"Platelets"},{"key":"10.1124\/jpet.116.238261_bib10","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1172\/JCI44098","article-title":"Seeing red: flushing out instigators of niacin-associated skin toxicity","volume":"120","author":"Dunbar","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.116.238261_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11883-016-0563-8","article-title":"Niacin Alternatives for Dyslipidemia: Fool\u2019s Gold or Gold Mine? Part I: Alternative Niacin Regimens","volume":"18","author":"Dunbar","year":"2016","journal-title":"Curr Atheroscler Rep"},{"key":"10.1124\/jpet.116.238261_bib12","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1194\/jlr.M300403-JLR200","article-title":"Niacin noncompetitively inhibits DGAT2 but not DGAT1 activity in HepG2 cells","volume":"45","author":"Ganji","year":"2004","journal-title":"J Lipid Res"},{"key":"10.1124\/jpet.116.238261_bib13","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1161\/CIRCRESAHA.110.223925","article-title":"A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse","volume":"107","author":"Gao","year":"2010","journal-title":"Circ Res"},{"key":"10.1124\/jpet.116.238261_bib14","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/9550","article-title":"Inducible cyclooxygenase may have anti-inflammatory properties","volume":"5","author":"Gilroy","year":"1999","journal-title":"Nat Med"},{"key":"10.1124\/jpet.116.238261_bib15","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.pbb.2012.02.012","article-title":"Nicotinic acid induces antinociceptive and anti-inflammatory effects in different experimental models","volume":"101","author":"Godin","year":"2012","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.116.238261_bib16","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1172\/JCI42273","article-title":"Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice","volume":"120","author":"Hanson","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.116.238261_bib17","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/HYPERTENSIONAHA.113.01639","article-title":"Endogenous prostaglandin D2 and its metabolites protect the heart against ischemia-reperfusion injury by activating Nrf2","volume":"63","author":"Katsumata","year":"2014","journal-title":"Hypertension"},{"key":"10.1124\/jpet.116.238261_bib18","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/FPC.0b013e32831270eb","article-title":"Pharmacological effects of lipid-lowering drugs recapitulate with a larger amplitude the phenotypic effects of common variants within their target genes","volume":"18","author":"Knouff","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/jpet.116.238261_bib19","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.bcp.2005.11.019","article-title":"Niacin induces PPARgamma expression and transcriptional activation in macrophages via HM74 and HM74a-mediated induction of prostaglandin synthesis pathways","volume":"71","author":"Knowles","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.116.238261_bib20","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1084\/jem.20160459","article-title":"PKA regulatory II\u03b1 subunit is essential for PGD2-mediated resolution of inflammation","volume":"213","author":"Kong","year":"2016","journal-title":"J Exp Med"},{"key":"10.1124\/jpet.116.238261_bib21","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.molmed.2006.02.005","article-title":"Emerging roles of DP and CRTH2 in allergic inflammation","volume":"12","author":"Kostenis","year":"2006","journal-title":"Trends Mol Med"},{"key":"10.1124\/jpet.116.238261_bib22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1300955","article-title":"Effects of extended-release niacin with laropiprant in high-risk patients","volume":"371","author":"Landray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.116.238261_bib23","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1172\/JCI77656","article-title":"EP3 receptor deficiency attenuates pulmonary hypertension through suppression of Rho\/TGF-\u03b21 signaling","volume":"125","author":"Lu","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.116.238261_bib24","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1172\/JCI41651","article-title":"Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells","volume":"121","author":"Lukasova","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.116.238261_bib25","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1038\/sj.jid.5700586","article-title":"Langerhans cells release prostaglandin D2 in response to nicotinic acid","volume":"126","author":"Maciejewski-Lenoir","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1124\/jpet.116.238261_bib26","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1038\/sj.emboj.7600660","article-title":"Prostaglandin D2 induces nuclear import of the sex-determining factor SOX9 via its cAMP-PKA phosphorylation","volume":"24","author":"Malki","year":"2005","journal-title":"EMBO J"},{"key":"10.1124\/jpet.116.238261_bib27","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.atherosclerosis.2006.07.014","article-title":"Nicotinic acid induces secretion of prostaglandin D2 in human macrophages: an in vitro model of the niacin flush","volume":"192","author":"Meyers","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1124\/jpet.116.238261_bib28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3109\/01902149409064387","article-title":"Effects of nicotinamide and niacin on bleomycin-induced acute injury and subsequent fibrosis in hamster lungs","volume":"20","author":"Nagai","year":"1994","journal-title":"Exp Lung Res"},{"key":"10.1124\/jpet.116.238261_bib29","doi-asserted-by":"crossref","first-page":"20979","DOI":"10.1073\/pnas.0707394104","article-title":"Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyDelta12 14 PGJ2","volume":"104","author":"Rajakariar","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.116.238261_bib30","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/jpet.116.238261_bib31","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.bcp.2003.09.014","article-title":"Stimulation of CD36 and the key effector of reverse cholesterol transport ATP-binding cassette A1 in monocytoid cells by niacin","volume":"67","author":"Rubic","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.116.238261_bib32","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1189\/jlb.0706424","article-title":"Contrary prostaglandins: the opposing roles of PGD2 and its metabolites in leukocyte function","volume":"81","author":"Sandig","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1124\/jpet.116.238261_bib33","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: in vivo veritas","volume":"122","author":"Sica","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.116.238261_bib34","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0006-291X(03)00342-5","article-title":"Molecular identification of nicotinic acid receptor","volume":"303","author":"Soga","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.116.238261_bib35","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1194\/jlr.R040592","article-title":"Niacin, an old drug with a new twist","volume":"54","author":"Song","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1124\/jpet.116.238261_bib36","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1172\/JCI59262","article-title":"Niacin and biosynthesis of PGD2by platelet COX-1 in mice and humans","volume":"122","author":"Song","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.116.238261_bib37","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1074\/jbc.M706839200","article-title":"Tetranor PGDM, an abundant urinary metabolite reflects biosynthesis of prostaglandin D2 in mice and humans","volume":"283","author":"Song","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.116.238261_bib38","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.4049\/jimmunol.174.6.3703","article-title":"Activation of the prostaglandin D2 receptor DP2\/CRTH2 increases allergic inflammation in mouse","volume":"174","author":"Spik","year":"2005","journal-title":"J Immunol"},{"key":"10.1124\/jpet.116.238261_bib39","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1194\/jlr.M031344","article-title":"Nicotinic acid and DP1 blockade: studies in mouse models of atherosclerosis","volume":"54","author":"Strack","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1124\/jpet.116.238261_bib40","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1742-7843.2008.00364.x","article-title":"Effects of niacin on cell adhesion and early atherogenesis: biochemical and functional findings in endothelial cells","volume":"104","author":"Tavintharan","year":"2009","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1124\/jpet.116.238261_bib41","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1172\/JCI37413","article-title":"Glucocorticoid protects rodent hearts from ischemia\/reperfusion injury by activating lipocalin-type prostaglandin D synthase-derived PGD2 biosynthesis","volume":"119","author":"Tokudome","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.116.238261_bib42","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nm824","article-title":"PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect","volume":"9","author":"Tunaru","year":"2003","journal-title":"Nat Med"},{"key":"10.1124\/jpet.116.238261_bib43","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0090-6980(02)00042-4","article-title":"Lipocalin-type and hematopoietic prostaglandin D synthases as a novel example of functional convergence","volume":"68-69","author":"Urade","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1124\/jpet.116.238261_bib44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/jbt.2570050104","article-title":"Niacin attenuates bleomycin-induced lung fibrosis in the hamster","volume":"5","author":"Wang","year":"1990","journal-title":"J Biochem Toxicol"},{"key":"10.1124\/jpet.116.238261_bib45","doi-asserted-by":"crossref","first-page":"9869","DOI":"10.1074\/jbc.M210695200","article-title":"Molecular identification of high and low affinity receptors for nicotinic acid","volume":"278","author":"Wise","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.116.238261_bib46","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.yjmcc.2013.04.023","article-title":"Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction","volume":"62","author":"Yan","year":"2013","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/jpet.116.238261_bib47","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/ni.1876","article-title":"The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway","volume":"11","author":"Yang","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1124\/jpet.116.238261_bib48","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1194\/jlr.M020917","article-title":"Niacin increases HDL biogenesis by enhancing DR4-dependent transcription of ABCA1 and lipidation of apolipoprotein A-I in HepG2 cells","volume":"53","author":"Zhang","year":"2012","journal-title":"J Lipid Res"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524195110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524195110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.116.238261","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T15:53:22Z","timestamp":1739980402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524195110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0022356524195110"],"URL":"https:\/\/doi.org\/10.1124\/jpet.116.238261","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Niacin Promotes Cardiac Healing after Myocardial Infarction through Activation of the Myeloid Prostaglandin D2 Receptor Subtype 1","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.116.238261","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}